Skip to content

CLARITY-Gastric01: Sonesitatug Vedotin Doubles Survival in Gastric Cancer | ESMO 2026

Dr. Vilma Barcia Hospital Universitario La Luz

Type: Expert pick
Congress: ESMO 2026
Published: November 8, 2026
Topic: Gastrointestinal

More on gastrointestinal cancers

Everything on gastrointestinal cancers

CheckMate 8HW final results: dual checkpoint inhibition in MSI-H/dMMR metastatic colorectal cancer
Publication pick. Annals of Oncology. November 2, 2026.
HARMONi-GI1: Ivonescimab Improves Survival in Biliary Tract Cancer | ESMO 2026
Dr. Vilma Barcia. Expert pick. ESMO 2026.
FDA NEWS | AZUR 1 Update in Rectal Cancer
Regulatory news. FDA. October 19, 2026.
Atezolizumab approved with fluoropyrimidine + oxaliplatin for adjuvant Stage III dMMR Colon Cancer (adults & peds ≥2 yrs).
Regulatory news. FDA. October 12, 2026.
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Publication pick. NEJM. October 9, 2026.
MATTERHORN: perioperative durvalumab plus FLOT improves overall survival
Publication pick. The Lancet. October 6, 2026.

The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.

Email address

Your role

Your country

How we use your details